Clopidogrel is a generic oral tablet that’s prescribed to help prevent stroke and heart attack in certain adults. It’s available as the brand-name drug Plavix. The cost of clopidogrel, with and ...

Clopidogrel is a generic prescription medication. It is FDA-approved to help prevent cardiovascular events such as heart attack and stroke in certain adults. Specifically, clopidogrel is approved to ...

Are you taking Clopidogrel? Are you aware of the dangers of combining Clopidogrel with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side ...

Commonly prescribed treatment options to prevent recurrent stroke include aspirin, clopidogrel, and an aspirin/dipyridamole combination. In the double-blind randomized PRoFESS trial, 20,332 clinically ...

A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in patients at high risk of recurrent cardiovascular events after coronary stent ...

Gastrointestinal complications are an important problem of antithrombotic therapy. Proton-pump inhibitors (PPIs) are believed to decrease the risk of such complications, though no randomized trial has ...

A comprehensive analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests that clopidogrel, a commonly prescribed blood thinner, is more effective than aspirin in preventing ...

Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have high rates of major vascular events. We evaluated the efficacy and safety of the antiplatelet ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...

The antiplatelet drug clopidogrel helps prevent stent-associated thrombosis, but the antiplatelet effects are quite variable and the clinical consequences can be serious. New findings show that the ...

People at risk of a cardiac event after a percutaneous coronary intervention (PCI) stent procedure who received long-term antiplatelet therapy with clopidogrel were 29% less likely to die than those ...